NYMOX PHARMACEUTICAL CORPORATION Employee Benefits Expense
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) reported Employee Benefits Expense of $3.29 million for the 3-month period ending 2021-09-30, per its 6-K filed 2021-11-12.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:EmployeeBenefitsExpense · last filed 2021-11-12
- NYMOX PHARMACEUTICAL CORPORATION employee benefits expense for the quarter ending 2021-09-30 was $3.29M, a 20.51% decline year-over-year.
- NYMOX PHARMACEUTICAL CORPORATION employee benefits expense for the quarter ending 2021-06-30 was $3.98M, a 35.88% increase year-over-year.
- NYMOX PHARMACEUTICAL CORPORATION employee benefits expense for the quarter ending 2020-09-30 was $4.14M.
- NYMOX PHARMACEUTICAL CORPORATION employee benefits expense for the quarter ending 2020-06-30 was $2.93M.
| Period end | Employee Benefits Expense 3 month | Employee Benefits Expense 6 month | Employee Benefits Expense 9 month |
|---|---|---|---|
| 2021-09-30 | $3.29M 6-K · filed 2021-11-12 | $7.27M derived: sum of 2 quarters · filed 2021-11-12 | $9.70M 6-K · filed 2021-11-12 |
| 2021-06-30 | $3.98M 6-K · filed 2021-08-13 | $6.41M 6-K · filed 2021-08-13 | |
| 2020-09-30 | $4.14M 6-K · filed 2021-11-12 | $7.07M derived: sum of 2 quarters · filed 2021-11-12 | $9.71M 6-K · filed 2021-11-12 |
| 2020-06-30 | $2.93M 6-K · filed 2021-08-13 | $5.57M 6-K · filed 2021-08-13 |